Jump to content

5-Cl-bk-MPA

From Wikipedia, the free encyclopedia
5-Cl-bk-MPA
Legal status
Legal status
  • DE: NpSG (Industrial and scientific use only)
  • UK: Class B
Identifiers
  • 1-(5-chlorothiophen-2-yl)-2-(methylamino)propan-1-one
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC8H10ClNOS
Molar mass203.68 g·mol−1
3D model (JSmol)
  • O=C(C(C)NC)c1ccc(Cl)s1
  • InChI=1S/C8H10ClNOS/c1-5(10-2)8(11)6-3-4-7(9)12-6/h3-5,10H,1-2H3
  • Key:VTSPXQPERGVFBV-UHFFFAOYSA-N

5-Chloro-β-keto-methiopropamine (5-Cl-βk-MPA) is a recreational designer drug with stimulant effects.[citation needed] It is a substituted cathinone derivative with a thiophene core, closely related to better known drugs such as βk-Methiopropamine and mephedrene.[citation needed]

Legality

[edit]

Hungary

[edit]

5-Cl-βk-MPA was first identified in Hungary in 2017,[1] and was made illegal in 2018.[2]

Italy

[edit]

5-Cl-βk-MPA was made illegal in Italy in 2020.[3]

See also

[edit]

References

[edit]
  1. ^ "Analytical data for 5Cl-bk-MPA" (PDF). Hungarian Institute for Forensic Science. 15 December 2007.
  2. ^ "Decree No 39/2018: Substances or groups of compounds classified as new psychoactive substances". Minister for Human Capacities. European Commission. 8 November 2018. Amending Minister for Human Capacities Decree No 55/2014 of 30 December 2014
  3. ^ "DECRETO 13 marzo 2020. Aggiornamento delle tabelle contenenti l'indicazione delle sostanze stupefacenti e psicotrope" [Update of the tables containing the indication of narcotic and psychotropic substances]. Official Gazette (in Italian). The Republic of Italy. 13 March 2020. di cui al decreto del Presidente della Repubblica 9 ottobre 1990, n. 309 e successive modificazioni ed integrazioni. Inserimento nella tabella I e nella tabella IV di nuove sostanze psicoattive. (20A01820) (GU Serie Generale n.85 del 30-03-2020) [as per the decree of the President of the Republic October 9, 1990, n. 309 and subsequent amendments and additions. Inclusion in Table I and Table IV of new psychoactive substances. (20A01820) (GU General Series n.85 of 30-03-2020)]